Similar articles

• Traditional and alternative research designs and methods in clinical pediatric psychopharmacology.

  Fava M. Fava M. J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1292-303. doi: 10.1097/00004583-199610000-00016. J Am Acad Child Adolesc Psychiatry. 1996. PMID: 8885583 Review.
• Understanding Rx options for the youngest patients.

  Enos G. Enos G. Behav Healthc Tomorrow. 2001 Aug;10(4):SR26-8. Behav Healthc Tomorrow. 2001. PMID: 11496582 No abstract available.
• Minimal brain dysfunction (neurological impairment) in children.

  Werry JS. Werry JS. N Z Med J. 1974 Aug 14;80(521):94-100. N Z Med J. 1974. PMID: 4608527 No abstract available.
• DSM-III-R and pediatric psychopharmacology.

  Rapoport JL. Rapoport JL. Psychopharmacol Bull. 1985;21(4):803-6. Psychopharmacol Bull. 1985. PMID: 3911250 Clinical Trial. No abstract available.
• Psychopharmacology in child and adolescent psychiatry: a review of the past five years.

  Campbell M, Spencer EK. Campbell M, et al. J Am Acad Child Adolesc Psychiatry. 1988 May;27(3):269-79. doi: 10.1097/00004583-198805000-00001. J Am Acad Child Adolesc Psychiatry. 1988. PMID: 3288611 Review. No abstract available.